S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ARTV Artiva Biotherapeutics Inc

4.44

0.43 (10.72%)

15 Feb 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Artiva Biotherapeutics (NASDAQ:ARTV)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Artiva Biotherapeutics Charts.

Artiva Biotherapeutics (NASDAQ:ARTV)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Artiva Biotherapeutics Charts.

Artiva Biotherapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 30 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
Thursday 30 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
Tuesday 12 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 23 October 2024 (4 months ago) • Edgar (US Regulatory)

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
Wednesday 23 October 2024 (4 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 14 September 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 14 September 2024 (5 months ago) • Edgar (US Regulatory)

More Artiva Biotherapeutics Inc News Articles

Great Portland Estates

Canadian Silver Hunter

AyuJoy Herbals (PK)

BNP Paribas Issuance BV

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions